Q8IIT5 AF NFT

Inactive protein tyrosine kinase pTKL

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihd3z3wtjbi2fxv3tgi7zfridjbieg2gkfnu5i2rimlhgibvfi6ae/metadata.json
IPFS of structure file: 
bafybeibvjxanldo4pzexck3dencj6awmbpzobfp4eoyfnmxvxalfvzn6yq/AF-Q8IIT5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x79387714350Be024a8CEbae6DDa6530bD09b565E
First NFT owner address (bech32): 
genesis10yu8w9p4p0szf2xwhtndmfjnp0gfk4j7yr6ylu
Current NFT ID #319471 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
319471
Accession (UniProt):
Q8IIT5
Name::
Inactive protein tyrosine kinase pTKL
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8IIT5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8IIT5|PTKL_PLAF7 Inactive protein tyrosine kinase pTKL OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=pTKL PE=1 SV=2 MGNTLDSNKPKNFVTYADYKYIGKLNNKNEHHGIGIILYNSGESFYGSFINGKKEGKGIYIDKNLTRYINTWVDNKVFGKVKVVPYNSNRVYYFYYKNYMIEKCIYFDNNINNKESHHKNNIYNNYDNNSYNNNSCDDEEKRKYPIGVTKFKEDLSNYIHSTHIMKKNNKLFNKNDNEYNIFSSSLSYSSDSENINLLDILKKKKNKKNKKNKKKKNKKTKNTQILSCTQHKMYEHNMNESNFTKKDNVNCEHTDKMNISLHEKNDKKNEKKNEKKNKKKKLFKYFSNNIENLIIENYQTWSLREVIQWLMLCNVPVKWLISFYKNNITGDKLKYININTIRNELGIIAYGHAIKILQLIKNLQVMAYNKKFNNLIQIEEYKNYIRQKENTNKNIKKGKNIKKEKKKKKEKNIKKEKKKKKKETKKFNNMDKKYIDLAIHKNVKNIQNDTFYNKHENIYNCKNQTNFIYQNDSEIKKIMNKKKVSFEYDNNEEKKKKNIIKFIKNNKSLQNSNGEYYLINHLSKGICSDSIFYKSSQSKSSSQLSSPLSSPLSSPSPSSSPSSSPSSSPSSSPSSSPSPSSSPSPSSSPSSSPSSSPSSPPSPLSYKDNFPISSSCSSLERLPSYEKKLLSSSQSNIEHIKNLPLDVLSNNNSSANIKIKKSKSKYNNDKKEQKKLPLILNKSSSEFSPSHSYTSKSYHYNIKPSLQSSSNNSSDSSYSISSTCSSSSSYVSSLYSNRSNDILNFYRNKIIKYCNNIYMNTKLAYSYMNGFIIPHEDLIFIHPIENYYMDNTNEKNNINNPYTKEKIMNHNFSFNTKNNTSFIDINTNIFSSNKQQNINNFGKYKKMKSRMFKGKYMGKEVAIKILVGKIKNFKKLHQILYNLYNLRHSNLVLIMGVSIHYPFVFIIYEYMKNKCLFSYLHCIKYKHVYISTFLQRYKTLLHITQQEKIKKTNNINNNNNINHNNINNNNINHNNINHNNINNNNINNNNINYNKDYNNKKKKEDEQHNIEHQDTFIDLPEKSNISSDDNNSTDISQIQKENFHFLNKKIEENKNIIYDDHTSTLSDHSIHNINKSYDNVYKNKMNIFHYQHNVLCGAYDNNDNNINDNDIYCNNIYDNNINDNHIYCNNINDNHIYCNNINDNHIYCNNIYDHHKNTSLNSKEQNTDHNIEQINECNKYASETKYNIKKSNLKNNIISHKNFQKCNQIQMNQPYTFPPYQKELSSYLKNEKIKRKRKVLFSYLKTHIHFNSQQINDQHNRLSVQKIMKIITDVTLACTYLEKEKMSPINLKPTNILLDESLNAKISDFGISKIENCLDMNIDYSYKISSNSVIKINKKEYEQKKAKKIKIVNKNNNDLLYLYDHNNNVYKYNTQYIDVTYNNSYPSIFYWTPPEILRGKKNKKFYSDIYAFGIILWEMLSNDIPYNYPFASHIMAVVGYANEELSFNNIPVSIQSLIKACVNRNKYKRPTFEHILKTISTLYQKANTKVEDALISFMDGT